A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial).
| Image |  |
|---|---|
| Description | scientific article published on 16 December 2017 |
| Author/s |
author: Tim Friede Klarissa Stürner Tobias Djamsched Faizy Friedemann Paul Christoph Heesen Roland Martin |
| Publication date | December 16, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |